210 related articles for article (PubMed ID: 11136884)
1. Giant cell arteritis is more prevalent in urban than in rural populations: results of an epidemiological study of primary systemic vasculitides in Germany.
Reinhold-Keller E; Zeidler A; Gutfleisch J; Peter HH; Raspe HH; Gross WL
Rheumatology (Oxford); 2000 Dec; 39(12):1396-402. PubMed ID: 11136884
[TBL] [Abstract][Full Text] [Related]
2. Doubled prevalence rates of ANCA-associated vasculitides and giant cell arteritis between 1994 and 2006 in northern Germany.
Herlyn K; Buckert F; Gross WL; Reinhold-Keller E
Rheumatology (Oxford); 2014 May; 53(5):882-9. PubMed ID: 24425780
[TBL] [Abstract][Full Text] [Related]
3. No difference in the incidences of vasculitides between north and south Germany: first results of the German vasculitis register.
Reinhold-Keller E; Herlyn K; Wagner-Bastmeyer R; Gutfleisch J; Peter HH; Raspe HH; Gross WL
Rheumatology (Oxford); 2002 May; 41(5):540-9. PubMed ID: 12011378
[TBL] [Abstract][Full Text] [Related]
4. Epidemiological study of primary systemic vasculitides among adults in southern Spain and review of the main epidemiological studies.
Romero-Gómez C; Aguilar-García JA; García-de-Lucas MD; Cotos-Canca R; Olalla-Sierra J; García-Alegría JJ; Hernández-Rodríguez J
Clin Exp Rheumatol; 2015; 33(2 Suppl 89):S-11-8. PubMed ID: 25437862
[TBL] [Abstract][Full Text] [Related]
5. Stable incidence of primary systemic vasculitides over five years: results from the German vasculitis register.
Reinhold-Keller E; Herlyn K; Wagner-Bastmeyer R; Gross WL
Arthritis Rheum; 2005 Feb; 53(1):93-9. PubMed ID: 15696553
[TBL] [Abstract][Full Text] [Related]
6. The epidemiology of the primary systemic vasculitides in northwest Spain: implications of the Chapel Hill Consensus Conference definitions.
Gonzalez-Gay MA; Garcia-Porrua C; Guerrero J; Rodriguez-Ledo P; Llorca J
Arthritis Rheum; 2003 Jun; 49(3):388-93. PubMed ID: 12794795
[TBL] [Abstract][Full Text] [Related]
7. Incidence, Prevalence, and Survival of Biopsy-Proven Giant Cell Arteritis in Northern Italy During a 26-Year Period.
Catanoso M; Macchioni P; Boiardi L; Muratore F; Restuccia G; Cavazza A; Pipitone N; Mancuso P; Luberto F; Salvarani C
Arthritis Care Res (Hoboken); 2017 Mar; 69(3):430-438. PubMed ID: 27214746
[TBL] [Abstract][Full Text] [Related]
8. Influence of age, sex, and place of residence on clinical expression of giant cell arteritis in northwest Spain.
Gonzalez-Gay MA; Garcia-Porrua C; Amor-Dorado JC; Llorca J
J Rheumatol; 2003 Jul; 30(7):1548-51. PubMed ID: 12858456
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology of biopsy proven giant cell arteritis in northwestern Spain: trend over an 18 year period.
González-Gay MA; Garcia-Porrua C; Rivas MJ; Rodriguez-Ledo P; Llorca J
Ann Rheum Dis; 2001 Apr; 60(4):367-71. PubMed ID: 11247867
[TBL] [Abstract][Full Text] [Related]
10. Contemporary prevalence estimates for giant cell arteritis and polymyalgia rheumatica, 2015.
Crowson CS; Matteson EL
Semin Arthritis Rheum; 2017 Oct; 47(2):253-256. PubMed ID: 28551169
[TBL] [Abstract][Full Text] [Related]
11. Stable incidence of systemic vasculitides in schleswig-holstein, Germany.
Herlyn K; Hellmich B; Gross WL; Reinhold-Keller E
Dtsch Arztebl Int; 2008 May; 105(19):355-61. PubMed ID: 19629246
[TBL] [Abstract][Full Text] [Related]
12. Incidence of giant cell arteritis in Western Norway 1972-2012: a retrospective cohort study.
Brekke LK; Diamantopoulos AP; Fevang BT; Aβmus J; Esperø E; Gjesdal CG
Arthritis Res Ther; 2017 Dec; 19(1):278. PubMed ID: 29246164
[TBL] [Abstract][Full Text] [Related]
13. Incidence Trends and Mortality of Giant Cell Arteritis in Southern Norway.
Andersen JB; Myklebust G; Haugeberg G; Pripp AH; Diamantopoulos AP
Arthritis Care Res (Hoboken); 2021 Mar; 73(3):409-414. PubMed ID: 31909871
[TBL] [Abstract][Full Text] [Related]
14. Incidence and prevalence of large vessel vasculitis (giant cell arteritis and Takayasu arteritis) in northern Italy: A population-based study.
Muratore F; Boiardi L; Mancuso P; Restuccia G; Galli E; Marvisi C; Macchioni P; Rossi PG; Salvarani C
Semin Arthritis Rheum; 2021 Aug; 51(4):786-792. PubMed ID: 34148007
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology of systemic vasculitis: a ten-year study in the United Kingdom.
Watts RA; Lane SE; Bentham G; Scott DG
Arthritis Rheum; 2000 Feb; 43(2):414-9. PubMed ID: 10693883
[TBL] [Abstract][Full Text] [Related]
16. A prospective study of vasculitis patients collected in a five year period: evaluation of the Chapel Hill nomenclature.
Sørensen SF; Slot O; Tvede N; Petersen J
Ann Rheum Dis; 2000 Jun; 59(6):478-82. PubMed ID: 10834866
[TBL] [Abstract][Full Text] [Related]
17. Incidence and prevalence of giant cell arteritis in Ontario, Canada.
Barra L; Pope JE; Pequeno P; Saxena FE; Bell M; Haaland D; Widdifield J
Rheumatology (Oxford); 2020 Nov; 59(11):3250-3258. PubMed ID: 32249899
[TBL] [Abstract][Full Text] [Related]
18. Rate of Comorbidities in Giant Cell Arteritis: A Population-based Study.
Mohammad AJ; Englund M; Turesson C; Tomasson G; Merkel PA
J Rheumatol; 2017 Jan; 44(1):84-90. PubMed ID: 27803140
[TBL] [Abstract][Full Text] [Related]
19. Cancer preceding giant cell arteritis: a case-control study.
Kermani TA; Schäfer VS; Crowson CS; Hunder GG; Ytterberg SR; Matteson EL; Gabriel SE; Warrington KJ
Arthritis Rheum; 2010 Jun; 62(6):1763-9. PubMed ID: 20191583
[TBL] [Abstract][Full Text] [Related]
20. Giant cell arteritis in Jerusalem: a 12-year epidemiological study.
Sonnenblick M; Nesher G; Friedlander Y; Rubinow A
Br J Rheumatol; 1994 Oct; 33(10):938-41. PubMed ID: 7921754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
